Detailed Notes on pyrogen test
This was accompanied by revisions to the eu Pharmacopoeia in 2016, which provided recombinant issue C (rFC) as a substitute process, once more subject to validation prerequisites. However, this Modification specially attested that ‘the use of other reagents for instance recombinant variable C as a substitution for the amebocyte lysate removes usi